Skip to main content
PLOS One logoLink to PLOS One
. 2021 Feb 22;16(2):e0247298. doi: 10.1371/journal.pone.0247298

Sweet chestnut standardized fractions from sustainable circular process and green tea extract: In vitro inhibitory activity against phytopathogenic fungi for innovative applications in green agriculture

Annalisa Romani 1,2, Gabriele Simone 2,3, Margherita Campo 1,4,*, Lorenzo Moncini 3, Roberta Bernini 5
Editor: Vijai Gupta6
PMCID: PMC7899350  PMID: 33617600

Abstract

In the present study, the antifungal activities of two commercial tannins-rich dry fractions towards different filamentous fungi of agronomical and food interest were evaluated. In particular, a standardized fraction from sweet chestnut (Castanea sativa Mill.) wood by-products and a commercial green tea (Camellia sinensis L.) leaf extract were tested at different concentrations (0.1–5.0% and 0.2% w/v respectively). The Sweet Chestnut Wood fraction was produced in an industrial plant through an environmentally and economically sustainable process, involving hot-water extraction and a sequence of membrane filtration steps with different molecular cut-offs for fractionation and concentration of the active principles. The Sweet Chestnut Wood and Green Tea Leaf extracts were characterised via HPLC/DAD/MS quali-quantitative analysis. The first extract showed a polyphenolic content of 20.5% w/w, 100% hydrolysable tannins; the second one showed a polyphenolic content of 87.5% w/w, of which 96.2% epigallocatechin gallate and 3.8% epicatechin gallate. The antifungal activity of the Sweet Chestnut fraction in aqueous solutions was evaluated towards different filamentous fungi, in particular telluric phytopathogens (Fusarium oxysporum f. sp. radicis-lycopersici; Fusarium solani; Rhizoctonia solani; Sclerotium rolfsii) and post harvest pathogens (Botrytis cinerea, that can also attack field plants; Penicillium digitatum; Penicillium italicum), and compared to the activity of Green Tea Leaf extract solutions. The experimental results evidenced, for almost all tested fungi, inhibition of the mycelial growth rate in presence of tannins. The lowest inhibitions were observed for B. cinerea (7.5%, to 28.9%) and P. italicum (53.8% in 5.0% w/v Sweet Chestnut extract substrate). A proportional inhibitory effect to tannin concentration was observed for F. oxysporum f. sp. radicis-lycopersici and F. solani (from 33.7% to 56.6%), R. solani (from 29.7% to 68.8%) and P. digitatum (64.7% to 87.0%). The highest effect resulted for S. rolfsii, (5.0% to 100%).

Introduction

In the recent years, the European legislation aimed to strongly reduce the impact of agricultural practices on environment and on health and wellness of operators and consumers. Community new Directives and Regulations, gradually implemented by specific Legislative Decrees at national level, imposed the revision of all criteria and rules for the production, market and use of active substances and products for plant protection in the European Union. This led to a progressive reduction of use and doses of traditional chemicals and products, thus limiting or prohibiting the diffusion of the most harmful substances, and actually discouraging the use of traditional pesticides in favour of sustainable agriculture practices with low environmental impact and minimal or negligible risk for the health of operators and users of the finished products. Thanks to the introduction of innovative and increasingly advanced technologies respectful of the environment, such as integrated defence systems and search for new natural and ecological solutions, agrochemicals consumption recently fell from 140,000 to 95,000 tons average per year. The progressive entry into force of the new regulations determined, for 2018, a negative trend for traditional chemicals, whereas organic agrochemicals are today worth about 20% of the market.

In agricultural systems, fungal phytopathogens are responsible for 70% of the total losses caused by pathogenic microorganisms [1]. The infections can occur either in field or in post-harvest phase, inducing alterations in the development or death of plants and loss of products or of their organoleptic and nutritional properties. Moreover, some of them can be responsible for intoxications and allergic disorders due the production of mycotoxins and allergens. To counteract these pathogens, synthetic fungicides are necessary but the negative side effects of their use, including their toxicity, are relevant on both human health and environment. In consideration of the increasing attention devoted to develop sustainable and eco-friendly processes in crop production, plant extracts, mainly those particularly rich in tannins and other polyphenolic compounds, could represent a valid solution as an alternative to synthetic fungicides [2].

Tannins are a wide sub-class of naturally occurring compounds that belongs to the chemical class of polyphenols. The variability of their structures allows for a further distinction, mainly in hydrolysable and condensed tannins: the first are polyhydroxylated compounds, usually D-glucose, partially or totally esterified with phenolic acids such as gallic acid or ellagic acid to get, respectively, gallotannins and ellagitannins; condensed tannins are oligomers or polymers based on flavan-3-ol units, commonly catechin or epicatechin, linked via carbon-carbon bonds, in some cases esterified with gallic acid [3]. They play a role of defence for plants against pathogenic microorganisms and their action is based on both oxidative and toxicity mechanisms due to enzymatic inhibition, but also to the ability to selectively interact with lipids in bacterial membranes by modifying their properties and irreversibly damaging them. Since ancient times, tannins have been used as mordents in textiles, for tanning of leather and to clarify wines. Recent studies reported several biological properties that make them suitable also for more specific applications in agronomy, veterinary, cosmetics, food, medicine and phytotherapy [412]. Hydrolyzable tannins, in particular tannic acid, are known for their ability to induce beneficial effects on human health including anti-mutagenic, anticancer and antioxidant activities. In addition, their ability to reduce serum cholesterol and triglycerides and to suppress lipogenesis by insulin has been well documented in the literature [13, 14]. The effect of hydrolysable tannins on membrane lipids was evaluated by studies on liposomes, whose results showed dose-dependent and time-dependent damage to the lipid bilayer by all of the tested compounds. A significant ability of gallic and ellagic derivatives to inhibit the synthesis of chitin, an essential component of the yeast cell wall, has been demonstrated; this inhibition could be one of the main factors that specifically determine the action against yeasts [15]. Condensed tannins show interesting antioxidant, anti-allergy, anti-hypertensive, and antimicrobial activities [16, 17]. In particular, several studies reported the antioxidant and antimicrobial properties of Green Tea (Camellia sinensis L.) Leaf (GTL) extracts, due to the high content of condensed tannins, mainly epigallocatechin gallate (EGCG). The antimicrobial effects of these extracts were demonstrated against gram-positive and gram-negative bacteria as Escherichia coli, Salmonella spp., Staphylococcus aureus, Enterococcus spp., fungi as Candida albicans and viruses (e.g., HIV, Herpes simplex, influenza) with Minimum Inhibitory Concentrations (MICs) in the range from 0.156 to 0.313 mg/mL of extract [1821].

Plant extracts rich in hydrolysable tannins generally have more complex chemical compositions and they are also less stable with respect to condensed tannins rich extracts, so there are some objective difficulties both in the study of their composition and biological properties, and in obtaining industrial standardized and stable products to be marketed. Nowadays, the most of the scientific results on matrices rich in hydrolysable tannins concern chestnut, oak and pomegranate. Among them, sweet chestnut (Castanea sativa Mill.) extracts are the most water-soluble, well industrially standardized and available at low costs.

In the present study, the in vitro inhibitory effect of one industrial, standardized and sustainable natural fraction from Sweet Chestnut Wood (SCW) was assessed against selected phytopathogenic fungi of agronomical interest, and compared to the activity of one registered commercial GTL extract, at different concentrations. The SCW fraction under study is produced by applying an industrial circular and sustainable process whose products were previously optimized and chemically characterized for their content in hydrolysable tannins, studied for their specific antioxidant properties, and compared with pomegranate, myrtle and other natural extracts, also containing hydrolysable tannins or different subclasses of polyphenols [2224]. In particular, the above mentioned SCW fraction and GTL extract were tested against telluric phytopathogens (Fusarium oxysporum f. sp. radicis-lycopersici; Fusarium solani; Rhizoctonia solani; Sclerotium rolfsii) and post-harvest pathogens (Botrytis cinerea, that can also attack field plants; Penicillium digitatum; Penicillium italicum). All these fungi can grow either as saprophytic, consuming the decaying matter, or as pathogens. Fusarium, Rhizoctonia and Sclerotium can attack a wide range of cultivated herbaceous plants causing various damages, like roots rot and the damping-off of seedlings and adult plants. Moreover, genus such as Sclerotium can produce sclerotia that can enable them to survive on harsh conditions on the soil and re-infect the crop year by year. B. cinerea is a pathogen that can attack either plants in soil and their products in post-harvest phase. The main host are grapevine, but they can attack also strawberries, tomatoes and other plants, striking fruits and sometimes also stems and leaves. Finally, P. digitatum and P. italicum are mainly known as pathogens of fruits in post-harvest phase, which cause serious losses annually. An infected lesion starts to be saggy and watery, then the mycelium emerges and starts to sporulate. The spores can be dispersed extremely easily and can re-infect the material in the nearby. To the best of our knowledge, tannin-rich extracts were investigated for their effects against bacteria and yeasts, but few studies are available on their effect against filamentous fungi, whereas the same industrial SCW fraction was previously studied [22], compared with other polyphenols-rich extracts, against pathogenic bacteria of agricultural interest such as Pseudomonas savastanoi and Pseudomonas syringae by both in vitro tests and on economically relevant species such as olive tree, kiwi, tomato and carrot, within the activities of the European Project LIFE EVERGREEN, “Environmentally friendly biomolecules from agricultural wastes as substitutes of pesticides for plant diseases control”, LIFE13 ENV/IT/000461, concluded in 2016. The activities are still carrying on in the new LIFE Project Plants for Plants, “Boost conventional agriculture’s confidence: new organic bio-stimulants to reduce water, nutrients and pesticide demand”, LIFE18 ENV/NL/000043.

In this study, both the SCW dry fraction and GTL extract were chemically characterized by HPLC/DAD/MS for their contents in polyphenolic secondary metabolites, before testing them against the above mentioned phytopathogens. The parallel tests with the commercial GTL extract, rich in condensed tannins, EGCG in particular as demonstrated by HPLC/DAD/MS analysis, allowed for comparing the effects of the SCW fraction to those of a widely investigated product whose antimicrobial properties are exploited for different purposes such as textiles antimicrobial treatments and food safety and quality. The presence of gallic acid units, in both hydrolysable tannins from SCW fraction and EGCG from GTL extract, is believed to play an important role in the mechanism of antimicrobial activity [25, 26].

This study is based on the above reported previous findings and considerations, as a prosecution of the research activities on sustainable products rich in natural compounds. It is aimed at an extension of the possible applications of this natural, sustainable industrial fraction to further targets in a productive sector like the agro-industry, where there is a large demand of new and innovative standardized, industrialised products economically and environmentally sustainable. The natural SCW fraction under study could represent a valid innovation in the market of agro-pharmaceuticals in general, also considering that nowadays several natural products and preparations are commonly developed and marketed in a limited context or as non-standardized formulations, often not competitive at an industrial scale. This study could represent a first step for the development of standardised and industrialised ecological crop protection products, suitable for use in green agriculture, in compliance with the regulations and according to environmental sustainability and health safety.

Materials and methods

Chemicals

All solvents (HPLC grade), formic acid (ACS reagent) and EGCG were purchased from Sigma Aldrich Chemical Company Inc. (Milwaukee, Wisconsin, USA). Gallic and ellagic acids, of analytical grade, were purchased from Extrasynthèse S.A. (Lyon, Nord-Genay, France). HPLC-grade water was obtained via double-distillation and purification with a Labconco Water Pro PS polishing station (Labconco Corporation, Kansas City, USA).

Extracts

The SWC dry extract was a commercial fraction furnished by GRUPPO MAURO SAVIOLA Srl (Viadana, MN, Italy). This fraction is obtained after ten circular and solvent free process streams by the industrial tannin extraction and concentration/purification plant operating in Radicofani (SI, Italy), previously described [23, 27]. Briefly, the ten process streams are: (1) filtration of tannin broths; (2) permeation from nanofiltration step-1; (3) concentration from nanofiltration step-1; (4) concentration from nanofiltration step-1 (after cooling); (5) permeation from nanofiltration step-2; (6) concentration from nanofiltration step-2; (7) osmosis permeation; (8) osmosis concentration; (9) settled fraction from clarification step; and (10) spray-dried material obtained from fraction 6 (commercial SWC dry extract under examination). The GTL was the commercial dry extract known as TEAVIGO® (DSM Nutritional Products, Heerlen, Netherlands).

Phytopathogens

The phytopathogens used for this work and their source are shown in Table 1. All fungi, in collection at the CRISBA research center (Grosseto, Italy) where the in vitro tests are performed, were cultivated on PDA (Formedium ltd., Norfolk, UK) at 25°C and, when necessary, kept at 4°C.

Table 1. Phytopathogens used and their original source.

Fungal strain Source
Botrytis cinerea SAS405 Strawberry (Italy) a
Fusarium oxysporum f. sp. radicis-lycopersici 8627 Tomato (Italy) a
Fusarium solani 10798 Passionflower (Italy) a
Rhizoctonia solani RB4 Tobacco (Italy) a
Sclerotium rolfsii 10827 Tomato (Italy) a
Penicillium digitatum CECT20796 Rotten fruit (Spain) b
Penicillium italicum FVP10 Tangerine (Italy) c

a Mycological Laboratory of Plant Pathology of the Agricultural Science, Alimentary and Agro-environmental Department, University of Pisa, Italy.

b Spanish Type Culture Collection (CECT), University of Valencia, Spain.

c Department of Soil, Plant and Food Science, University of Bari “Aldo Moro”, Italy.

HPLC/DAD/ESI-MS analysis

SWC fraction and GTL extract were analyzed by using a HP-1200 liquid chromatograph equipped with a DAD detector and a HP 1100 MSD API-electrospray (Agilent Technologies, Santa Clara, CA) operating in negative and positive ionization mode. A Luna, C18 250×4.60 mm, 5 μm column (Phenomenex, Torrance, CA), operating at 26 °C was used. The eluents were H2O (adjusted to pH 3.2 with HCOOH) and CH3CN. A four-step linear solvent gradient starting from 100% H2O up to 100% CH3CN was performed with a flow rate of 0.8 mL/min over a 55 minutes period, as previously described [23, 27]. Mass spectrometer operating conditions were: gas temperature 350 °C at a flow rate of 10.0 L/min, nebulizer pressure 30 psi, quadrupole temperature 30 °C and capillary voltage 3500 V. The fragmentor was set at 120 eV.

Quali-quantitative analysis

The polyphenols present in the extracts were identified by using data from HPLC/DAD and HPLC/MS analyses, by comparing their retention times, UV-Vis and mass spectra with those of the available specific commercial standards. Each compound was quantified by HPLC/DAD, using a five-point regression curve built with the available standards. Calibration curves with r2 ≥0.9998 were considered. The concentration of each compound was calculated by applying the appropriate corrections for changes in molecular weight. Gallic acid was calibrated at 280 nm and ellagic acid at 254 nm with the appropriate standards; EGCG and epicatechin gallate (ECG) were calibrated at 280 nm using EGCG as reference. The evaluation of the polyphenol content was carried out in triplicate. The results were recorded as mean values with standard deviations ≤ 5%. The polyphenolic extracts were tested at tannin concentrations between 0.364 mM and 18.200 mM (SCW) and 3.828 mM (GTL), calculated according to the reported HPLC/DAD analysis results.

Antifungal screening

In vitro test of radial growth inhibition

The inhibitory effect of extracts on fungal growth were tested using the “poison food technique method”, according to the literature [28]. The SCW fraction was added to the PDA at the final concentrations of 1.0%, 2.0% and 5.0% w/v, the pH was adjusted at 7.0 adding KOH 10 M, autoclaved and then poured in 85 mm Petri dishes. A control (PDA without the extracts) was used. For fungi that were totally inhibited at these concentrations, two additional media were prepared with SCW at 0.1% and 0.5% w/v for other tests. The plates were inoculated at the center with 5 mm mycelium discs cut from the 7-day-old cultures.

Otherwise, P. italicum was inoculated using a conidial suspension according to the procedure described by Kinay et al., 2006 with some modifications [29]. Briefly, the conidial suspension was prepared scraping the conidia from a 7-day-old colony and diluting it in distilled water to reach 106 conidia/mL; 50 μL of this suspension were placed in a 5 mm hole made in the center of the solidified medium. The plates were then incubated at 25°C in darkness and colonies diameters were recorded every 24 h, until the reaching of the Petri dish’s border. The diameters values were the mean of three replicates for each thesis. The percentage of inhibition value was calculated at the last interval of time, according to the following equation [30].

I=[(CFcCFt)/CFc]x100

where I = inhibition (%); CFc = control growth (diameter); CFt = treatment growth (diameter).

Comparison test between SCW fraction and GTL extract

To compare the effects of SWC fraction and GTL extract, the previous test was repeated using the extract at 0% (control) and 2% and a media prepared with GTL at 0.2% w/v. The preparation of the media, the inoculation and the data collection were carried out as described above (see “In vitro test of radial growth inhibition”).

Sclerotia germination inhibition test

The aim of this test is to evaluate the inhibitory property of the SCW extract on sclerotia germination. Three media were prepared as previously described, adding SCW extract to the PDA at the final concentrations of 0% (control), 0.5% and 2.0% w/v. The mature sclerotia were obtained from a 45-day-old colony grown on PDA and dried at 30°C for 20 h to induce the eruptive germination. The sclerotia were sterilized with NaClO (2% active chlorine) for 3 minutes and washed in distilled sterile water for 3 times [31]. Each Petri dish was inoculated with 20 sclerotia and 5 replicates were made for each treatment (a total of 100 sclerotia for each thesis). After 5 days, the number of germinated sclerotia was registered and the sclerotial germination inhibition rate was calculated according to the following equation [31]:

IRSG=[(NCKNt)/NCK]x100

where: IRSG is the sclerotial germination inhibition rate (%);

NCK = germination rate on control thesis;

Nt = germination rate on treated control.

Statistical analyses

Data were elaborated using DSAASTAT program through the variance analysis (ANOVA). The means separation was carried out using the Duncan’s H.M. multiple range test prior angular transformation for the percentage values. The statistical significance was evaluated at p<0.01 for each test and at p<0.05 for the sclerotial germination test [32].

Results and discussion

Quali-quantitative HPLC/DAD/ESI-MS characterization of SCW fraction and GTL extract

Both SCW fraction and GTL extract were commercially available. The SWC fraction was obtained via aqueous extraction and membranes technology purification and concentration from SWC wood by green methodologies. The industrial plant for hydrolysable tannins extraction, previously described [23, 27], was designed for the economically and environmentally sustainable recovery of wood chips yielded as a by-product during the processing of SWC wood. The raw extract, obtained through hot water extraction, was purified and concentrated by a sequence of filtration steps on membranes with different molecular cut-offs, to obtain different fractions enriched in hydrolysable tannins with specific biological properties. Two of these industrial fractions are commercial: one liquid purified and concentrated fraction and the spray-dried powder obtained from this latter. The latter was the fraction investigated in the present study, and selected for its better characteristics of chemical and biological stability and industrial standardization. GTL extract was also commercially available as TEAVIGO® (see “Materials and methods” section).

SCW fraction and GTL extract were analyzed by HPLC/DAD/ESI-MS; the results are reported in Table 2. According to data already reported by Campo et al. [23], the polyphenols content in the SCW fraction consists entirely of hydrolysable tannins. With respect to the studies concerning the characterization of the wood matrix of sweet chestnut, the heaviest molecules and oligomers are not present in consideration of the hydrolysis process of their partial or total amounts during the extraction procedure in hot water, but the representative compounds of the vegetal species under study, as vescalagin and castalagin, are mostly preserved. Their amounts in the tested sample are, respectively, 23.1% and 19.8% w/w (on total tannins); small amounts of their partial hydrolysis products as vescalin, castalin and pedunculagin I were detected (4.5%, 4.2% and 4.9% w/w on total tannins, respectively). The dried SCW fraction was chemically stable as demonstrated by control HPLC/DAD analysis repeated after 6 and 12 months.

Table 2. Quali-quantitative HPLC/DAD/MS analysis of SCW fraction and GTL extract.

SCW fraction mg/ga mmol/ga
Vescalin 9.284 ± 0.322 0.015 ± 0.0007
Castalin 8.633 ± 0.371 0.014 ± 0.0007
Pedunculagin I 9.964 ± 0.401 0.013 ± 0.0006
Monogalloyl glucose I 5.321 ± 0.098 0.016 ± 0.0004
Gallic acid 14.537 ± 0.281 0.086 ± 0.0018
Monogalloyl glucose II 4.961 ± 0.213 0.015 ± 0.0006
Roburin D 5.817 ±0.194 0.003 ± 0.0001
Vescalagin 47.379 ± 1.605 0.051 ± 0.0018
Dehydrated tergallagic-C-glucoside 2.091 ± 0.094 0.003 ± 0.0002
Castalagin 40.713 ± 1.378 0.044 ± 0.0016
Digalloyl glucose 3.698 ± 0.075 0.008 ± 0.0002
O-Galloyl-castalagin isomer 17.002 ± 0.376 0.031 ± 0.0007
Trigalloyl glucose 12.658 ± 0.382 0.020 ± 0.0006
Tetragalloyl glucose 9.996 ± 0.246 0.013 ± 0.0003
Ellagic acid 8.747 ± 0.732 0.029 ± 0.0025
Pentagalloyl glucose 4.637 ± 0.298 0.005 ± 0.0003
Total tannins 205.438 ± 7.380 0.364 ± 0.0130
GTL extract mg/g mmol/g
EGCG 841.610 ± 18.211 1.838 ± 0.040
ECG 33.698 ± 0.671 0.076 ± 0.002
Total tannins 875.308 ± 18.882 1.914 ± 0.042

aData are expressed as mg and mmol of compound per gram of dry extract.

GTL extract showed a tannins content of 875.308 mg/g, 96.2% EGCG and 3.8% epicatechin gallate (ECG) (% w/w individual compounds on total tannins). Thus, as expected, it contains only monomeric condensed tannins derived from galloylated flavan-3-olic units, chemically more stable than hydrolysable tannins (Table 2). EGCG has a structural analogy with hydrolysable tannins found in SCW fraction, represented by the presence of the gallic acid unit, which is believed to play an important role in the mechanism of antimicrobial activity (Fig 1).

Fig 1. Chemical structures of the main polyphenols found in SCW fraction and GTL extract.

Fig 1

In vitro antifungal screening

Table 3 shows the tannins concentrations, expressed as mM, for each one of the tested solutions. They were calculated based on the weight of dry extract in aqueous solution and the chemical quali-quantitative characterization data shown in Table 2, in particular using the results expressed as mmol of total tannins in the extract. According to the results, the mM concentration of EGCG and ECG in the tested solution of 0.2% w/v GTL extract (3.83 mM) is similar to that of hydrolysable tannins in the 1.0% w/v SCW solution (3.64 mM); thus, the most direct comparison is between the results obtained for these two samples. Fig 2 shows the images of mycelial growth for the investigated fungi in the presence of different SCW concentrations. The experiment data of antifungal tests showed that both extracts inhibited the mycelial growth rate for almost all tested fungi. The results are shown in Fig 3 as growth inhibition (%) compared to the control. The lower growth rate inhibition was observed for B. cinerea (7.5%, 8.1% and 28.9% with SCW fraction at 1.0%, 2.0% and 5.0% w/v, respectively) and P. italicum, that was inhibited only with 5.0% w/v of SCW fraction (53.8% of inhibition), while it was slightly stimulated on lower doses. A proportional inhibitory effect to SCW concentration was observed for F. oxysporum f. sp. radicis-lycopersici, F. solani (from 33.7% to 56.6%), R. solani (from 29.7% to 68.8%) and P. digitatum (from 64.7% to 87.0%). The best result was obtained with S. rolfsii, that was totally inhibited with all concentrations of the extracts, so more tests were carried out at lower doses. A total inhibition of mycelial growth of S. rolfsii was confirmed with SCW fraction at 1.0% and 2.0% w/v, while an inhibition of the 86% on SCW 0.5% w/v (despite the high variability between replicas) and only 5.0% on SCW 0.1% was observed. In the literature, similar results were reported by testing gallic and ellagic acid against B. cinerea [33], Fusarium spp. [34] and R. solani [35].

Table 3. Tannins concentrations (mM) in the tested solutions, according to the % w/v of extracts and the quali-quantitative HPLC/DAD/MS data.

Tested concentration of extract (w/v) 0.1% 0.2% 0.5% 1.0% 2.0% 5.0%
Tannins in SCW solutions (mM) 0.364 1.82 3.64 7.28 18.2
Tannins in GTL solution (mM) 3.83

Fig 2. Mycelial growth of the investigated fungi on the different SCW thesis.

Fig 2

Fig 3. Growth inhibition percentage for each tested phytopathogenic fungi.

Fig 3

Comparison test between SCW fraction and GTL extract

Since the encouraging results obtained with the SCW fraction, we compared the effect of the 1% w/v concentration of this fraction with a comparable amount of GTL extract. In the literature, the effects of GTL extract against bacteria, yeast and some filamentous fungi are reported, but data about fungi of agronomic interest are lacking.

The results previously obtained with SCW fraction were confirmed and showed a better efficacy in some cases compared to GTL extract, as shown in Table 4. P. italicum was not inhibited by both the extracts. B. cinerea was scarcely inhibited (25.7%) but the results were better if compared to the SCW extract (7.5%). The inhibition of F. oxysporum f. sp. radicis-lycopersici and F. solani was of 13.9% and 25.9%, that was inferior compared to the 33.7% and 34.2% on tannins enriched medium. Better results were obtained against R. solani and P. digitatum: the inhibition with green tea and tannins was, respectively, 65% and 29.8% for R. solani and 65.2% and 64.8% for P. digitatum. In the latter case, the differences between the treatments are negligible and statistically not significant. Against S. rolfsii the inhibition (100%) was much higher for SCW fraction compared to GTL extract (46.6%). Some authors reported similar results against Botrytis with comparable concentrations of polyphenolic extract of GTL [36], while, at the best of our knowledge, literature data about the GTL extract against other fungi tested in this work are missing. The results show a better efficacy of SCW extract compared with GTL extract against the Fusarium and Sclerotium. A similar effect was observed against P. digitatum.

Table 4. Inhibitory effect (%) on mycelial growth of the tested pathogens*.

SCW extract (1% w/v) GTL extract (0.2% w/v)
Botrytis cinerea 7.5a 25.7b
Fusarium oxysporum f. sp. radicis-lycopersici 33.7a 13.9b
Fusarium solani 34.2° 25.9b
Penicillium italicum -6.5° 3.3a
Penicillium digitatum 64.8° 65.2a
Rhizoctonia solani 29.8° 65.0b
Sclerotium rolfsii 100c 46.6b

* Different letters in each row indicate a significant statistical difference (p<0.01).

Sclerotia inhibition test

In consideration of the effects of SCW fraction against S. rolfsii, additional tests were performed on the sclerotial germination. These tests were carried out using the lowest SCW concentration that inhibited the fungal growth (0.5% w/v) and the mean concentration used in this work (2.0% w/w). After 5 days of treatment with SCW fraction at 0.5% and 2.0% w/w, the sclerotial germination inhibition rate resulted, respectively, of 45.5% and 100%. At the end, the mycelium covered the entire plate on control, the colonies with the SCW fraction 0.5% w/w showed a maximum of 1 cm of diameter and no growth was observed with SCW 2.0% w/w. This implies that although the sclerotia can germinate, even if in lower percentage, the mycelium grows with difficulties. These results could be interesting to be applied in products to treat sclerotia-infested soil and prevent or reduce further infections. More studies will be carried out to explore this opportunity.

According to the activities and data above reported, this research fits into the context of the recent scientific studies, conducted at both basic and applicative research level, on the chemical characterization and biological properties of natural extracts and semi-finished products in order to standardize and industrialize green processes for the sustainable production of innovative references for applications in different sectors, to replace chemical synthetic active ingredients and additives.

Only recently the antimicrobial activity of hydrolysable tannins was explored with interesting results, but most of the scientific papers available concern the food safety sector. The results of these studies, some of which are in an applicative phase with industrial natural extracts, have shown the possibility of using hydrolyzable tannins from chestnut and other vegetal species as a potential substitute of synthetic food preservatives due to their antioxidant and antimicrobial properties [3741]. These innovative applications are in line with the request from the market for natural and sustainable products, as a consequence of the reduction or elimination of traditional chemicals.

The same hydrolysable tannins fraction under study was previously tested [22], compared with other polyphenols-rich extracts, against pathogenic bacteria of agricultural interest such as P. savastanoi and P. syringae both in vitro and in vivo on economically relevant crops such as olive tree, kiwi, tomato and carrot. The work, conducted in collaboration with different research partners including university research centers and private companies, was mainly in the scope of the European Project LIFE—EVERGREEN. These results, together with the ones obtained for natural extracts rich in galloylated condensed tannins, constitute a context and a basis for this work.

According to the above reported results, interesting progresses are conceivable for some of the tested microorganisms, e.g. P. digitatum and S. rolfsii, as the percentage inhibitory effect of SCW fraction on mycelial growth is not only high from itself, but also equal or much higher than such found for GTL extract. Further studies are in progress to assess the in vitro and in vivo activity of SCW fraction towards other microorganisms and its stability under different conditions, to evaluate possible formulations for the finished products and eventual synergistic effects with other natural active extracts. In our opinion, this is the first report on the possibility of application of SCW extracts and natural active fractions in the green agricultural reality.

In order to verify and consolidate the reported results, further studies are in progress in vitro with similar pathogens and in vivo on economically relevant species such as olive tree, kiwi, tomato, basil and vitis. For the practical applications, the lower and medium doses are the most realistic in terms of application for practical reasons as costs and mixing operations. Compared to the GTL extract, the SCW fraction efficacy is higher or at least comparable in most of the analysed cases, but the sustainability of the industrial process and the lower costs, that make it affordable for large scale productions, are the main factors able to assess the SCW fraction as a valid natural antimicrobial for green agriculture together with GTL extract.

Conclusion

This paper describes for the first time the activity of SCW fraction and GTL extract on pathogenic fungi of agronomic interest. While some results are anyway promising (as for P. digitatum and S. rolfsii), others could be the basis of further studies to investigate an eventual synergistic effect with other natural extracts with different action mechanisms. Relevant are the results for SCW fraction by a sustainable and reproducible industrial process using by-products of wood processing and environmental management of chestnut forests. The low cost of the raw materials and the efficiency of the process allow for obtaining a final product in large amounts, at a low final price, making it suitable for use in agriculture. Moreover, the compatibility with food uses permits an eventual application as a food preservative due to the antimicrobial and antioxidant activities. Further in vitro and in vivo studies are in progress to explore the effective potentiality of SCW fraction as an alternative to the use of synthetic fungicides in agriculture. A preliminary Life Cycle Assessment (LCA) study was performed, in comply with ISO 14040 and ISO 14044, for the quantitative assessment of the environmental, economic and social impacts deriving from the productive process of the commercial fractions, mainly related to soil and crops. The study was performed according to the reported extraction and purification/concentration methods of active compounds from sweet chestnut by the industrial extraction plant, consisting of a hot water-extraction system coupled with a membrane separation technology system, followed by the spray drying process to obtain the two commercially available finished products. The other fractions are reintroduced into the process to be further refined or added to the extraction water. They were taken into account parameters such as: climate change; ozone depletion; human toxicity; non-cancer effects; freshwater eutrophication; freshwater ecotoxicity; land use; water resource depletion; mineral and fossil resource depletion; loss of global species diversity and their functional traits as biodiversity parameters. The main benefits produced by using the investigated SCW fraction are related to all parameters evaluated, despite the large consumption of water for polyphenol extraction, thanks to the possibility of reusing water after filtration and purification treatments. These LCA results relate, in particular, the sustainability of the circular production process for obtaining sweet chestnut tannins. A further development of the LCA study, for the use of natural extracts in green agriculture, will include a specific evaluation of the economic and environmental sustainability, non-human toxicity and non-cancer effects, in replacing synthetic chemicals in green agriculture with antimicrobials and antioxidants based on natural active ingredients.

Acknowledgments

The authors are grateful to GRUPPO MAURO SAVIOLA Srl (Viadana, MN, Italy) and Natural-mente Srl (Florence, Italy).

Data Availability

All relevant data are within the manuscript and figures.

Funding Statement

This research is part of the following projects: Tuscany Region, POR FESR 2014/2020. Nat-BackeryInnov "Innovative production of a bakery line based on natural functional extracts for wellness and sports”; Tuscany Region, POR CREO FESR 2014-2020 “Formulation of new sustainable products for agriculture based on natural extracts”, LIFE18 ENV/NL/000043 PlantsforPlants: “Boost conventional agriculture’s confidence: new organic bio-stimulants to reduce water, nutrients and pesticide demand”.

References

  • 1.Oerke EC. Crop losses to pests. J. Agric. Sci. 2006; 144: 31–43. [Google Scholar]
  • 2.Al-Samarrai G, Sing H, Syarhabil M. Evaluating eco-friendly botanicals (natural plant extracts) as alternatives to synthetic fungicides. Ann. Agric. Envron. Med. 2012; 19:673–676. [PubMed] [Google Scholar]
  • 3.Bule M, Khan F, Nisar MF, Niaz K. Tannins (hydrolysable tannins, condensed tannins, phlorotannins, flavono-ellagitannins) In: Nabavi S, Saeedi M, Nabavi S, Sanches Silva A, editors. Recent Advances in Natural Products Analysis. Elsevier; 2020. pp. 132–146. [Google Scholar]
  • 4.Okuda T. Systematic effects of chemically distinct tannins in medicinal plants. Phytochem. 2005; 66:2012–2031. [DOI] [PubMed] [Google Scholar]
  • 5.Buzzini P, Arapitsas P, Goretti E, Branda B, Turchetti P, Pinelli P, et al. Antimicrobial and antiviral activity of hydrolysable tannins. Mini-Rev. Med. Chem. 2008; 8:1179–1187. 10.2174/138955708786140990 [DOI] [PubMed] [Google Scholar]
  • 6.Turchetti B, Pinelli P, Buzzini P, Romani A, Heimler D, Franconi F, et al. In vitro antimycotic activity of some plant extracts towards yeast and yeast-like strains. Phytother. Res. 2005; 19:44–49. 10.1002/ptr.1622 [DOI] [PubMed] [Google Scholar]
  • 7.Lupini C, Cecchinato M, Scagliarini A, Graziani R, Catelli E. In vitro antiviral activity of chestnut and quebracho woods extracts against avian reovirus and metapneumovirus. Res. Vet. Sci. 2009; 87:482–487. 10.1016/j.rvsc.2009.04.007 [DOI] [PubMed] [Google Scholar]
  • 8.Chiarini A, Micucci M, Malaguti M, Budriesi R, Ioan P, Lenzi M, et al. Sweet chestnut (Castanea sativa Mill.) bark extract: cardiovascular activity and myocyte protection against oxidative damage. Oxid Med. Cell Longev. 2013, 10.1155/2013/471790 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Bargiacchi E, Miele S, Romani A, Campo M. Biostimulant activity of hydrolyzable tannins from sweet chestnut (Castanea sativa Mill.). Acta Hort. 2013; 1009:111–116. [Google Scholar]
  • 10.Mastrogiovanni F, Bernini R, Basiricò L, Bernabucci U, Campo M, Romani A, et al. Antioxidant and anti-inflammatory effects of pomegranate peel extracts on bovine mammary epithelial cells BME-UV1. Nat. Prod. Res. 2018; 1–5; 10.1080/14786419.2018.1508149 [DOI] [PubMed] [Google Scholar]
  • 11.Mastrogiovanni F, Romani A, Santi L, Lacetera N, Bernini R. Anti-proliferative effect of pomegranate peel extracts on bovine peripheral blood mononuclear cells (PBMCs). Nat. Prod. Res. 2019; 10.1080/14786419.2019.1627350 [DOI] [PubMed] [Google Scholar]
  • 12.Mastrogiovanni F, Mukhopadhya A, Lacetera N, Ryan MT, Romani A, Bernini R, et al. Anti-inflammatory effects of pomegranate peel extracts on in vitro human intestinal Caco-2 cells and ex vivo porcine colonic tissue explants. Nutrients. 2019; 11:548–562, 10.3390/nu11030548 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Ong KC, Khoo HE, Das NP. Tannic acid inhibits insulin-stimulated lipogenesis in rat adipose tissue and insulin receptor function in vitro. Cell Mol. Life Sci. 1995; 51:577–584. 10.1007/BF02128747 [DOI] [PubMed] [Google Scholar]
  • 14.Yugarani T, Tan BKH, Das NP. The effects of tannic acid on serum lipid parameters and tissue lipid peroxides in the spontaneously hypertensive and Wistar Kyoto rats. Planta Med. 1992; 59:28–31. [DOI] [PubMed] [Google Scholar]
  • 15.Funtagawa K, Hayashi S, Shimonura H, Yoshida T, Hatano T, Ito H, et al. Antibacterial activity of hydrolizable tannins derived from medicinal plants against Helicobacter pylori. Microbiol. Immunol. 2004; 48:251–261. 10.1111/j.1348-0421.2004.tb03521.x [DOI] [PubMed] [Google Scholar]
  • 16.Romani A, Ieri F, Turchetti B, Mulinacci N, Vincieri FF, Buzzini P. Analysis of condensed and hydrolyzable tannins from commercial plant extracts. J. Pharm. Biomed. Anal. 2006; 41:415–420. 10.1016/j.jpba.2005.11.031 [DOI] [PubMed] [Google Scholar]
  • 17.Lizarraga D, Lozano C, Briede JJ, van Delft JH, Tourino S, Centelles JJ, et al. The importance of polymerization and galloylation for the antiproliferative properties of procyanidins-rich natural extracts. FEBS J. 2007; 274: 4802–4811. 10.1111/j.1742-4658.2007.06010.x [DOI] [PubMed] [Google Scholar]
  • 18.Chan EW, Soh EY, Tie PP, Law YP. Antioxidant and antibacterial properties of green, black and herbal teas of Camellia sinensis. Pharmacognosy Res. 2011; 3: 266–272. 10.4103/0974-8490.89748 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Jigisha A, Nishant R, Navin K, Pankaj G. Green tea: a magical herb with miraculous outcomes. Int. Res. J. Pharm. 2012; 3:139–148. [Google Scholar]
  • 20.Sharma A, Gupta S, Sarethy IP, Dang S, Gabrani R. Green tea extract: possible mechanism and antibacterial activity on skin pathogens. Food Chem. 2012; 135: 672–675. 10.1016/j.foodchem.2012.04.143 [DOI] [PubMed] [Google Scholar]
  • 21.Reygaert WC. The antimicrobial possibilities of green tea. Front. Microbiol. 2014; 5 10.3389/fmicb.2014.00434 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Biancalani C, Cerboneschi M, Tadini-Buoninsegni F, Campo M, Scardigli A, Romani A, et al. Global analysis of Type Three Secretion System and Quorum Sensing inhibition of Pseudomonas savastanoi by polyphenols extracts from vegetable residues. PloS one 2016; 11(3): 409–415. 10.1371/journal.pone.0163357 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Campo M, Pinelli P, Romani A. Hydrolyzable tannins from sweet chestnut fractions obtained by a sustainable and eco-friendly industrial process. Nat. Prod. Commun. 2016; 11: 109–415. [PubMed] [Google Scholar]
  • 24.Romani A, Campo M, Pinelli P. HPLC/DAD/MS Analyses and Anti-Radical Activity of Hydrolyzable Tannins from Different Vegetal Species. Food Chem. 2012; 130 (1): 214–221. [Google Scholar]
  • 25.Imperatori F, Barlozzari G, Scandrigli A, Romani A, Macrì G, Polinori N, et al. Leishmanicidal activity of green tea leaves and pomegranate peel extracts of L. infantum. Nat. Prod. Res. 2019; 33: 3465–3471. 10.1080/14786419.2018.1481841 [DOI] [PubMed] [Google Scholar]
  • 26.Basiricò L, Morera P, Dipasquale D, Bernini R, Santi L, Romani A, et al. (-)-Epigallocatechin-3-gallate and hydroxytyrosol protect against oxydative damage and improve anti-inflammatory response in bovine mammary epithelial cells (BME-UV1). Animal. 2019. 10.1017/S1751731119001356 [DOI] [PubMed] [Google Scholar]
  • 27.Lucarini M, Durazzo A, Romani A, Campo M, Lombardi-Boccia G, Cecchini F. Bio-based compounds from grape seeds: a biorefinery approach. Molecules. 2018; 23:1888 10.3390/molecules23081888 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Singh P, Srivastava B, Kumar A, Kumar R, Dubey N, Gupta R. Assessment of Pelargonium graveolens oil as plant-based antimicrobial and aflatoxin suppressor in food preservation. J. Sci. Food Agric. 2008; 88: 2421–2425. [Google Scholar]
  • 29.Kinay P, Mansour MF, Gabler F, Margosan DA, Smilanick JL. Characterization of fungicide-resistant isolates of Penicillium digitatum collected in California. Crop Prot. 2007; 26: 647–656. [Google Scholar]
  • 30.Cavalcanti de Albuquerque C, Camara TR, Mariano RDLR, Willadino L, Marcelino C Junior, Ulisses C. Antimicrobial action of the essential oil of Lippia gracilis Schauer. Braz. Arch. Biol. Technol. 2006; 49: 527–535. [Google Scholar]
  • 31.Li Y, He F, Lai H, Xue Q. Mechanism of in vitro antagonism of phytopathogenic Sclerotium rolfsii by actinomycetes. Eur. J. Plant Pathol. 2017; 149: 299–311. [Google Scholar]
  • 32.Tian J, Ban X, Zeng H, He J, Huang B, Wang Y. Chemical composition and antifungal activity of essential oil from Cicuta virosa L. var. latisecta. Celak. Int. Food Microbiol. 2011; 145: 464–470. 10.1016/j.ijfoodmicro.2011.01.023 [DOI] [PubMed] [Google Scholar]
  • 33.Tao S, Zhang S, Tsao R, Charles MT, Yang R, Khanizadeh S. In vitro antifungal activity and mode of action of selected polyphenolic antioxidant on Botrytis cinerea. Archiv. Phytopathol. Plant Protect. 2010; 43: 1564–1578. [Google Scholar]
  • 34.Wu HS, Wang Y, Zhang CY, Bao W, Ling N, Liu DY, et al. Growth of in vitro Fusarium oxysporum f. sp. niveum in chemically defined media amended with gallic acid. Biol. Res. 2009; 42: 297–304. [PubMed] [Google Scholar]
  • 35.Osorio E, Flores M, Hernandez D, Ventura J, Rodriguez R, Aguilar CN. Biological efficency of polyphenolic extracts from pecan nut shell (Carya illinoensis), pomegranate husk (Punica granatum) and cresote bush leaves (Larrea tridentata Cov.) against plant pathogenic fungi. Ind. Crops Prod. 2010; 31: 153–157. [Google Scholar]
  • 36.Liu HM, Guo JH, Cheng YJ, Liu P, Long CA, Deng BX. Inhibitory activity of tea polyphenol and Hanseniaspora uvarum against Botrytis cinerea infections. Lett. Appl. Microbiol. 2010; 51: 258–263. 10.1111/j.1472-765X.2010.02888.x [DOI] [PubMed] [Google Scholar]
  • 37.Bargiacchi E, Bellotti P, Costa G, Miele S, Pinelli P, Romani A, et al. Use of sweet chestnut tannin extract as an antioxidant, antimicrobial additive and to reduce nitrosamines and mycotoxins. 2014; PCT 0001422367 Gruppo Mauro Saviola S.R.L.
  • 38.Hoque MZ, Akanda AM, Miah MIH, Bhuiyan MKA, Miah MG, Begum F. In vitro screening of fungicides and tannins against fungal pathogens of jujube fruits. Progress. agric. 2016; 27(2): 154–161. [Google Scholar]
  • 39.Agnolucci M, Daghio M, Mannelli F, Secci G, Cristani C, Palla M, et al. Use of chitosan and tannins as alternatives to antibiotics to control mold growth on PDO Pecorino Toscano cheese rind. Food Microbiol. 2018; 92: 103598. [DOI] [PubMed] [Google Scholar]
  • 40.Messini A, Buccioni A, Minieri S, Mannelli F, Mugnai L, Comparini C, et al. Effect of chestnut tannin extract (Castanea sativa Miller) on the proliferation of Cladosporium cladosporioides on sheep cheese rind during the ripening. International Dairy Journal. 2018; 66: 6–12. [Google Scholar]
  • 41.Kõrge K, Bajić M, Likozar B, Novak U. Active chitosan-chestnut extract films used for packaging and storage of fresh pasta. IJFST. 2020. [Google Scholar]

Decision Letter 0

Vijai Gupta

29 Jul 2020

PONE-D-20-10008

Sweet chestnut (Castanea sativa Mill.) standardized fractions from sustainable circular process and green tea (Camellia sinensis L.) extract: in vitro inhibitory activity against phytopathogenic fungi for innovative applications in green agriculture

PLOS ONE

Dear Dr. Campo,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Your MS needs significant corrections before we consider this MS for further review for publication in PLOS One. Kindly do the needful changes as suggested by the reviewers and submit a point wise author response. 

Please submit your revised manuscript by Sep 12 2020 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols

We look forward to receiving your revised manuscript.

Kind regards,

Vijai Gupta, PhD in Microbiology

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2.We suggest you thoroughly copyedit your manuscript for language usage, spelling, and grammar. If you do not know anyone who can help you do this, you may wish to consider employing a professional scientific editing service.  

Whilst you may use any professional scientific editing service of your choice, PLOS has partnered with both American Journal Experts (AJE) and Editage to provide discounted services to PLOS authors. Both organizations have experience helping authors meet PLOS guidelines and can provide language editing, translation, manuscript formatting, and figure formatting to ensure your manuscript meets our submission guidelines. To take advantage of our partnership with AJE, visit the AJE website (http://learn.aje.com/plos/) for a 15% discount off AJE services. To take advantage of our partnership with Editage, visit the Editage website (www.editage.com) and enter referral code PLOSEDIT for a 15% discount off Editage services.  If the PLOS editorial team finds any language issues in text that either AJE or Editage has edited, the service provider will re-edit the text for free.

Upon resubmission, please provide the following:

  • The name of the colleague or the details of the professional service that edited your manuscript

  • A copy of your manuscript showing your changes by either highlighting them or using track changes (uploaded as a *supporting information* file)

  • A clean copy of the edited manuscript (uploaded as the new *manuscript* file)

3.Thank you for stating the following in the Financial Disclosure section:

[This research is part of the following projects:  Tuscany Region, POR FESR 2014/2020. Nat-BackeryInnov "Innovative production of a bakery line based on natural functional extracts for wellness and sports”; Tuscany Region, POR CREO FESR 2014-2020 “Formulation of new sustainable products for agriculture based on natural extracts”, LIFE18 ENV/NL/000043 - LIFE “PlantsforPlants”.].   

We note that one or more of the authors are employed by a commercial company: PIN scrl

  1. Please provide an amended Funding Statement declaring this commercial affiliation, as well as a statement regarding the Role of Funders in your study. If the funding organization did not play a role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript and only provided financial support in the form of authors' salaries and/or research materials, please review your statements relating to the author contributions, and ensure you have specifically and accurately indicated the role(s) that these authors had in your study. You can update author roles in the Author Contributions section of the online submission form.

Please also include the following statement within your amended Funding Statement.

“The funder provided support in the form of salaries for authors [insert relevant initials], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the ‘author contributions’ section.”

If your commercial affiliation did play a role in your study, please state and explain this role within your updated Funding Statement.

2. Please also provide an updated Competing Interests Statement declaring this commercial affiliation along with any other relevant declarations relating to employment, consultancy, patents, products in development, or marketed products, etc.  

Within your Competing Interests Statement, please confirm that this commercial affiliation does not alter your adherence to all PLOS ONE policies on sharing data and materials by including the following statement: "This does not alter our adherence to  PLOS ONE policies on sharing data and materials.” (as detailed online in our guide for authors http://journals.plos.org/plosone/s/competing-interests) . If this adherence statement is not accurate and  there are restrictions on sharing of data and/or materials, please state these. Please note that we cannot proceed with consideration of your article until this information has been declared.

Please include both an updated Funding Statement and Competing Interests Statement in your cover letter. We will change the online submission form on your behalf.

Please know it is PLOS ONE policy for corresponding authors to declare, on behalf of all authors, all potential competing interests for the purposes of transparency. PLOS defines a competing interest as anything that interferes with, or could reasonably be perceived as interfering with, the full and objective presentation, peer review, editorial decision-making, or publication of research or non-research articles submitted to one of the journals. Competing interests can be financial or non-financial, professional, or personal. Competing interests can arise in relationship to an organization or another person. Please follow this link to our website for more details on competing interests: http://journals.plos.org/plosone/s/competing-interests

Additional Editor Comments (if provided):

Dear Author, Your MS "Sweet chestnut (Castanea sativa Mill.) standardized fractions from sustainable circular process and green tea (Camellia sinensis L.) extract: in vitro inhibitory activity against phytopathogenic fungi for innovative applications in green agriculture" needs significant corrections before we consider this MS for further review for publication in PLOS One. Kindly do the needful changes as suggested by the reviewers and submit a point wise author response.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: Yes

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: This paper needs to be carefully reorganized with a clearly stated argument spelled out in the opening pages. The authors should work harder on the approach adopted, establish a clear theoretical background to contextualize the analysis and narrow the scope of the analysis to specific aspects. Apart from compiling key studies, a critical approach to the literature is required. There is a need of offering detailed insights regarding the main purpose of the paper and its contribution. The discussions require more structure and there is a need of offering a clear assessment of reviewed literature. The main contributions of the paper should be presented as part of the empirical discussions or critical assessment on the core research outcomes. The main contribution should be emphasised more and the concluding statements should be stronger. The paper presents its points in a rather descriptive manner, referring to relevant sources but without really discussing them. It brings up interesting points, but stating them rather than arguing for them. The research idea is not properly contextualised, as there is a need of offering a detailed review of relevant literature that help the authors developing the key arguments that support their proposed research. Data gathering and data analysis can be reconsidered and discussed more comprehensively. The lead up argument for the study and results section appear to be too loosely constructed. There is some discussion of the limitations of the study however these are not considered in terms of the implications on the study findings. Some bibliographic references are simply brought up without being developed, or without an adequate explanation as to why they are relevant.

Reviewer #2: Reviewer’s Report: PONE-D-20-10008

Sweet chestnut (Castanea sativa Mill.) standardized fractions from sustainable circular process and green tea (Camellia sinensis L.) extract: in vitro inhibitory activity against phytopathogenic fungi for innovative applications in green agriculture

Here are some minor corrections:

Line 316-318 figures title should be removed

Line 353 space should be removed

I suggest Accept the manuscript for publication in PLOS ONE.

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

Attachment

Submitted filename: Review Report_PLOS ONE - 16.6.2020.docx

PLoS One. 2021 Feb 22;16(2):e0247298. doi: 10.1371/journal.pone.0247298.r002

Author response to Decision Letter 0


30 Sep 2020

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

We would like to thank the Editors for their comments. We checked PLOS ONE style templates and ensured that our manuscript meets the style requirements.

2.We suggest you thoroughly copyedit your manuscript for language usage, spelling, and grammar. If you do not know anyone who can help you do this, you may wish to consider employing a professional scientific editing service.

We had the manuscript checked for language usage, spelling, and grammar and fixed some inaccuracies, as evidenced in the text of our Manuscript.

3.Thank you for stating the following in the Financial Disclosure section:

[This research is part of the following projects: Tuscany Region, POR FESR 2014/2020. Nat-BackeryInnov "Innovative production of a bakery line based on natural functional extracts for wellness and sports”; Tuscany Region, POR CREO FESR 2014-2020 “Formulation of new sustainable products for agriculture based on natural extracts”, LIFE18 ENV/NL/000043 - LIFE “PlantsforPlants”.].

We note that one or more of the authors are employed by a commercial company: PIN scrl

1. Please provide an amended Funding Statement declaring this commercial affiliation, as well as a statement regarding the Role of Funders in your study. If the funding organization did not play a role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript and only provided financial support in the form of authors' salaries and/or research materials, please review your statements relating to the author contributions, and ensure you have specifically and accurately indicated the role(s) that these authors had in your study. You can update author roles in the Author Contributions section of the online submission form.

Please also include the following statement within your amended Funding Statement.

“The funder provided support in the form of salaries for authors [insert relevant initials], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the ‘author contributions’ section.”

If your commercial affiliation did play a role in your study, please state and explain this role within your updated Funding Statement.

2. Please also provide an updated Competing Interests Statement declaring this commercial affiliation along with any other relevant declarations relating to employment, consultancy, patents, products in development, or marketed products, etc.

Within your Competing Interests Statement, please confirm that this commercial affiliation does not alter your adherence to all PLOS ONE policies on sharing data and materials by including the following statement: "This does not alter our adherence to PLOS ONE policies on sharing data and materials.” (as detailed online in our guide for authors http://journals.plos.org/plosone/s/competing-interests) . If this adherence statement is not accurate and there are restrictions on sharing of data and/or materials, please state these. Please note that we cannot proceed with consideration of your article until this information has been declared.

Please include both an updated Funding Statement and Competing Interests Statement in your cover letter. We will change the online submission form on your behalf.

Please know it is PLOS ONE policy for corresponding authors to declare, on behalf of all authors, all potential competing interests for the purposes of transparency. PLOS defines a competing interest as anything that interferes with, or could reasonably be perceived as interfering with, the full and objective presentation, peer review, editorial decision-making, or publication of research or non-research articles submitted to one of the journals. Competing interests can be financial or non-financial, professional, or personal. Competing interests can arise in relationship to an organization or another person. Please follow this link to our website for more details on competing interests: http://journals.plos.org/plosone/s/competing-interests

We would like to thank the Editors for pointing this. The affiliation reported in the manuscript has been completed by adding a lacking part of the description. PIN scrl is not a commercial company, but an University Center for educational and scientific services for the University of Florence, as now indicated (see the affiliations in the Title page). So the funder of this research is not PIN scrl, but Tuscany Region for projects POR FESR 2014/2020 Nat-BackeryInnov "Innovative production of a bakery line based on natural functional extracts for wellness and sports” and POR CREO FESR 2014-2020 “Formulation of new sustainable products for agriculture based on natural extracts”, and the European Community for LIFE Project Plants for Plants, “Boost conventional agriculture’s confidence: new organic bio-stimulants to reduce water, nutrients and pesticide demand project”, LIFE18 ENV/NL/000043. So we can exclude the existence of competing interests.

Reviewer #1: This paper needs to be carefully reorganized with a clearly stated argument spelled out in the opening pages. The authors should work harder on the approach adopted, establish a clear theoretical background to contextualize the analysis and narrow the scope of the analysis to specific aspects. Apart from compiling key studies, a critical approach to the literature is required. There is a need of offering detailed insights regarding the main purpose of the paper and its contribution. The discussions require more structure and there is a need of offering a clear assessment of reviewed literature. The main contributions of the paper should be presented as part of the empirical discussions or critical assessment on the core research outcomes. The main contribution should be emphasised more and the concluding statements should be stronger. The paper presents its points in a rather descriptive manner, referring to relevant sources but without really discussing them. It brings up interesting points, but stating them rather than arguing for them. The research idea is not properly contextualised, as there is a need of offering a detailed review of relevant literature that help the authors developing the key arguments that support their proposed research. Data gathering and data analysis can be reconsidered and discussed more comprehensively. The lead up argument for the study and results section appear to be too loosely constructed. There is some discussion of the limitations of the study however these are not considered in terms of the implications on the study findings. Some bibliographic references are simply brought up without being developed, or without an adequate explanation as to why they are relevant.

We would like to thank the reviewer for his/her comment. As he/she suggested, the paper has been reorganized, in particular the “Introduction” and “Results and Discussion” sections. Both the results and literature were discussed more in depth, also by adding some new references to recent studies, to better contextualize our study and explain the main purpose and contribution of the paper.

Reviewer #2: Reviewer’s Report: PONE-D-20-10008

Line 316-318 figures title should be removed: we would like to thank the reviewer for his/her comment. According to PlosOne Manuscript body formatting guidelines, “Each figure caption should appear directly after the paragraph in which they are first cited”. For this reason we have kept the figure captions in the same position.

Line 353 space should be removed: the space has been removed.

• Furthermore, although no requests were made, we have replaced the file of Figure 1 by uploading a new one of better quality, as we noticed that the previous image had an insufficient quality.

Attachment

Submitted filename: Response to Reviewers.doc

Decision Letter 1

Vijai Gupta

5 Jan 2021

PONE-D-20-10008R1

Sweet chestnut (Castanea sativa Mill.) standardized fractions from sustainable circular process and green tea (Camellia sinensis L.) extract: in vitro inhibitory activity against phytopathogenic fungi for innovative applications in green agriculture

PLOS ONE

Dear Dr. Campo,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

MS still needs a few corrections before it maybe considered for publication in PLSO One.  Kindly do the needful changes as motioned by the reviewers and submit a revised MS.  

Please submit your revised manuscript by Feb 19 2021 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols

We look forward to receiving your revised manuscript.

Kind regards,

Vijai Gupta, PhD in Microbiology

Academic Editor

PLOS ONE

Additional Editor Comments (if provided):

MS still needs a few corrections before it maybe considered for publication in PLSO One. Kindly do the needful changes as motioned by the reviewers and submit a revised MS.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #3: (No Response)

Reviewer #4: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #3: Partly

Reviewer #4: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #3: Yes

Reviewer #4: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #3: Yes

Reviewer #4: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #3: No

Reviewer #4: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #3: (No Response)

Reviewer #4: I have gone through the manuscript and found very informative research work on antimicrobial activities of extract took from tea in inhibitory test against pathogen. I strongly recommending to this research paper for accepting to publish in forthcoming issue of the journal.

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #3: No

Reviewer #4: Yes: I have gone through the manuscript and found very informative research work on antimicrobial activities of extract took from tea in inhibitory test against pathogen. I strongly recommending to this research paper for accepting to publish in forthcoming issue of the journal.

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

Attachment

Submitted filename: Comments_PLoS ONE 2.docx

PLoS One. 2021 Feb 22;16(2):e0247298. doi: 10.1371/journal.pone.0247298.r004

Author response to Decision Letter 1


20 Jan 2021

Dear PLOS ONE Editors and Reviewers,

All the authors would like to thank the Editor and Reviewers for their careful reading of the manuscript PONE-D-20-10008R1 entitled “Sweet chestnut standardized fractions from sustainable circular process and green tea extract: in vitro inhibitory activity against phytopathogenic fungi for innovative applications in green agriculture”.

The manuscript has been revised according to all Reviewers’ comments and all corrections have been marked-up in the copy labelled “Revised Manuscript with Track Changes”; as requested, also an unmarked version without tracked changes, labelled “Manuscript”, has been uploaded.

Comment 1:

Author should consider using either common name or scientific name in the title and use both on the first mention in the manuscript. Then choose which to use throughout and make it consistent.

For sweet chestnut and green tea, only common names were kept in the title; on the first mention both in the Abstract and in the text (Introduction section), common names with the complete scientific names are reported; only common names are used for the following mentions. Also pathogens names were checked and fixed.

Abstract: Line 39-40: “can attack also plants in the field” can be stated as “can also attack field plants”.

Done.

Comment 2:

Line 83: Should include the following reference:

Mohammed Bule et al. Tannins (hydrolysable tannins, condensed tannins, phlorotannins, flavono-ellagitannins). Recent Advances in Natural Products Analysis. Elsevier, 2020, pp. 132-146.

Though the introduction is relevant and theory based, sufficient information on previous findings is not presented well for the readers to follow the present study rationale.

The reference was added in the text.

The “Introduction” section has been revised and improved (lines 156-167 in particular) in order to let the readers better understand our study rationale.

Comment 3:

In method section: Lines 167-173: Author may consider including the flow diagram of the dry extraction process.

The flow diagram of the extraction and fractionation industrial process was already reported in a previous publication (Campo et al., 2016), so it is no more possible to use the figure. Here we cited the articles where we described accurately the whole process also by showing the flow diagram (Campo et al., 2016; Lucarini et al., 2018).

Comment 4:

Line 226-227: Must provide the reference to “previously described”.

As it could seem like a reference to literature, in the place of “as previously described”, we have inserted “as described above (see “In vitro test of radial growth inhibition”)”. The reference, indeed, is to what described in the previous paragraph.

Comment 5:

Line 266: Consider using “Campo et al.” instead of “this research group”.

“Campo et al.” was added instead of “this research group”.

Comment 6:

Line 275: Please clarify “6-months and 12-months” or “12-months”.

In the place of “The dried SCW fraction was chemically stable at the 6-months and 12-months as demonstrated by the analytical controls”, we added the following sentence: “The dried SCW fraction was chemically stable as demonstrated by control HPLC/DAD analysis repeated after 6 and 12 months.”. This new sentence should be more clear than the first one.

Comment 7:

Consider proofreading the manuscript.

The whole manuscript has been carefully revised and checked. Some typos were fixed and some sentences were re-written to make them more clear. Particular attention was paid to the English language.

Attachment

Submitted filename: Response to Reviewers.pdf

Decision Letter 2

Vijai Gupta

5 Feb 2021

Sweet chestnut standardized fractions from sustainable circular process and green tea extract: in vitro inhibitory activity against phytopathogenic fungi for innovative applications in green agriculture

PONE-D-20-10008R2

Dear Dr. Campo,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Vijai Gupta, PhD in Microbiology

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

All the comments have been addressed. Now paper can be accepted for publication in PLOS One.

Reviewers' comments:

Acceptance letter

Vijai Gupta

12 Feb 2021

PONE-D-20-10008R2

Sweet chestnut standardized fractions from sustainable circular process and green tea extract: in vitro inhibitory activity against phytopathogenic fungi for innovative applications in green agriculture

Dear Dr. Campo:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Vijai Gupta

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    Attachment

    Submitted filename: Review Report_PLOS ONE - 16.6.2020.docx

    Attachment

    Submitted filename: Response to Reviewers.doc

    Attachment

    Submitted filename: Comments_PLoS ONE 2.docx

    Attachment

    Submitted filename: Response to Reviewers.pdf

    Data Availability Statement

    All relevant data are within the manuscript and figures.


    Articles from PLoS ONE are provided here courtesy of PLOS

    RESOURCES